Literature DB >> 25191853

Osteoporosis presenting in pregnancy, puerperium, and lactation.

Christopher S Kovacs1.   

Abstract

PURPOSE OF REVIEW: To describe our current state of knowledge about the pathophysiology, incidence, and treatment of osteoporosis that presents during pregnancy, puerperium, and lactation. RECENT
FINDINGS: When vertebral fractures occur in pregnant or lactating women, it is usually unknown whether the skeleton was normal before pregnancy. Maternal adaptations increase bone resorption modestly during pregnancy but markedly during lactation. The net bone loss may occasionally precipitate fractures, especially in women who have underlying low bone mass or skeletal fragility prior to pregnancy. Bone mass and strength are normally restored postweaning. Transient osteoporosis of the hip is a sporadic disorder localized to one or both femoral heads; it is not due to generalized skeletal resorption. Anecdotal reports have used bisphosphonates, strontium ranelate, teriparatide, or vertebroplasty/kyphoplasty to treat postpartum vertebral fractures, but it is unclear whether these therapies had any added benefit over the spontaneous skeletal recovery that normally occurs after weaning.
SUMMARY: These relatively rare fragility fractures result from multifactorial causes, including skeletal disorders that precede pregnancy, and structural and metabolic stresses that can compromise skeletal strength during pregnancy and lactation. Further study is needed to determine when pharmacological or surgical therapy is warranted instead of conservative or expectant management.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25191853     DOI: 10.1097/MED.0000000000000102

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  13 in total

Review 1.  Transient osteoporosis of the hip: review of the literature.

Authors:  K Asadipooya; L Graves; L W Greene
Journal:  Osteoporos Int       Date:  2017-03-17       Impact factor: 4.507

2.  Long-term outcome of patients with pregnancy and lactation-associated osteoporosis (PLO) with a particular focus on quality of life.

Authors:  Martin Gehlen; Ana Doina Lazarescu; Christian Hinz; Michael Schwarz-Eywill; Michael Pfeifer; Subathira Balasingam; Anna Maier
Journal:  Clin Rheumatol       Date:  2019-08-29       Impact factor: 2.980

3.  Clinical characteristics and bisphosphonates treatment of rare pregnancy- and lactation-associated osteoporosis.

Authors:  Lu-Jiao Li; Jia Zhang; Peng Gao; Fang Lv; Yu-Wen Song; Xiao-Yan Chang; Di-Chen Zhao; Ou Wang; Yan Jiang; Xiao-Ping Xing; Wei-Bo Xia; Mei Li
Journal:  Clin Rheumatol       Date:  2018-06-26       Impact factor: 2.980

4.  Pregnancy-associated osteoporosis: a case-control study.

Authors:  P Hadji; J Boekhoff; M Hahn; L Hellmeyer; O Hars; I Kyvernitakis
Journal:  Osteoporos Int       Date:  2017-01-10       Impact factor: 4.507

5.  Incorporation of Flaxseed Flour as a Dietary Source for ALA Increases Bone Density and Strength in Post-Partum Female Rats.

Authors:  Danielle Cavalcante Ribeiro; Aline D'Avila Pereira; Fernanda Carvalho de Santana; Jorge Mancini-Filho; Eduardo Moreira da Silva; Carlos Alberto Soares da Costa; Gilson Teles Boaventura
Journal:  Lipids       Date:  2017-03-21       Impact factor: 1.880

Review 6.  Bone metabolism and osteoporosis during pregnancy and lactation.

Authors:  Abraham Yair Lujano-Negrete; Martha Cecilia Rodríguez-Ruiz; Cassandra Michele Skinner-Taylor; Lorena Perez-Barbosa; Jesus Alberto Cardenas de la Garza; Pedro Alberto García-Hernández; Luis Gerardo Espinosa-Banuelos; Luz Fernanda Gutierrez-Leal; Sofia Jezzini-Martínez; Dionicio Ángel Galarza-Delgado
Journal:  Arch Osteoporos       Date:  2022-02-19       Impact factor: 2.617

7.  Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up.

Authors:  I Kyvernitakis; T C Reuter; L Hellmeyer; O Hars; P Hadji
Journal:  Osteoporos Int       Date:  2017-09-30       Impact factor: 4.507

8.  Bone Density After Teriparatide Discontinuation With or Without Antiresorptive Therapy in Pregnancy- and Lactation-Associated Osteoporosis.

Authors:  Seunghyun Lee; Namki Hong; Kyoung Jin Kim; Chung Hyun Park; Jooyeon Lee; Yumie Rhee
Journal:  Calcif Tissue Int       Date:  2021-05-26       Impact factor: 4.333

Review 9.  Approach to the patient with pregnancy and lactation-associated osteoporosis: A case report and a review of the literature.

Authors:  Min Zhang; Ping Chen; Bin Li; Juan Du; Ting Pan; Jingyan Chen
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

10.  Clinical Case: Pregnancy lactation osteoporosis.

Authors:  Olga Loukadaki; Symeon Tournis; Sousana Gazi
Journal:  Mediterr J Rheumatol       Date:  2017-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.